» Articles » PMID: 16865184

Cationic, Linear Au(I) N-heterocyclic Carbene Complexes: Synthesis, Structure and Anti-mitochondrial Activity

Overview
Journal Dalton Trans
Specialty Chemistry
Date 2006 Jul 26
PMID 16865184
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Six linear, two-coordinate cationic Au(I) N-heterocyclic carbene complexes of the form [(R2Im)2Au]+ (R = Me 1, Me, Et 2, i-Pr 3, n-Bu 4, t-Bu 5 and Cy 6) have been prepared by the reaction of two equivalents of the appropriate dialkylimidazol-2-ylidene (R2Im) with (Me2S)AuCl in dmf. Single crystal structural studies for 1.PF6, 2.PF6), 3.Cl and 4-6.PF6 show that for all six complexes the gold(I) centres have quasi-linear C-Au-C coordination, with quasi-parallel pairs of aromatic imidazole planes, except in 5.PF6 where they are quasi-normal; in the latter, Au-C are 2.038(3), 2.033(3) A, cf. (e.g.) 2.027(2) A. Inter-cation Au...Au are close at 3.487(2), 3.525(2) A in 1PF6 and 2.PF6. The structural studies and low temperature NMR experiments provide no supportive evidence for the presence of pi back-bonding within this series of complexes. The lipophilicities of the six compounds, as estimated from the logarithm of the n-octanol-water partition coefficients (log P), varied across the series within the range -1.09 to 1.73. To investigate their potential as possible anti-mitochondrial anti-tumour agents, five of the compounds have been evaluated for their propensities to induce mitochondrial membrane permeabilization (MMP) in isolated rat liver mitochondria. At concentrations between 1-10 microM compounds 1.Br and 3-6.Cl induced dose-dependent, Ca2+-sensitive mitochondrial swelling at rates that increased with the lipophilicities of the complexes, with the most lipophilic compounds inducing the most rapid onset of swelling. The swelling was completely inhibited by cyclosporin A, the specific inhibitor of the mitochondrial permeability transition pore.

Citing Articles

Unveiling the cytotoxicity of a new gold(I) complex towards hepatocellular carcinoma by inhibiting TrxR activity.

Wang Y, Yuan H, Fang R, Zhang R, Wang W Acta Biochim Biophys Sin (Shanghai). 2024; 56(10):1537-1548.

PMID: 39314165 PMC: 11532207. DOI: 10.3724/abbs.2024155.


A New Class of Gold(I) NHC Complexes with Proapoptotic and Resensitizing Properties towards Multidrug Resistant Leukemia Cells Overexpressing BCL-2.

Bannwart F, Richter L, Stifel S, Rueter J, Lode H, Correia J J Med Chem. 2024; 67(17):15494-15508.

PMID: 39196554 PMC: 11403678. DOI: 10.1021/acs.jmedchem.4c01117.


Hydroamination of alkynes catalyzed by NHC-Gold(I) complexes: the non-monotonic effect of substituted arylamines on the catalyst activity.

Sirignano M, DAmato A, Costabile C, Mariconda A, Crispini A, Scarpelli F Front Chem. 2023; 11:1260726.

PMID: 38124702 PMC: 10731675. DOI: 10.3389/fchem.2023.1260726.


Copper complexes as prospective anticancer agents: and evaluation, selective targeting of cancer cells by DNA damage and S phase arrest.

Mahendiran D, Amuthakala S, Bhuvanesh N, Senthil Kumar R, Rahiman A RSC Adv. 2022; 8(30):16973-16990.

PMID: 35540520 PMC: 9080330. DOI: 10.1039/c8ra00954f.


Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Zaki M, Hairat S, Aazam E RSC Adv. 2022; 9(6):3239-3278.

PMID: 35518979 PMC: 9060267. DOI: 10.1039/c8ra07926a.